Unknown

Dataset Information

0

Puerarin Exerts Protective Effects on Wear Particle-Induced Inflammatory Osteolysis.


ABSTRACT: Wear particle-stimulated inflammatory bone destruction and the consequent aseptic loosening remain major postoperative problems for artificial joints. Studies have indicated that puerarin promotes osteogenesis and alleviates lipopolysaccharide-induced osteoclastogenesis in vitro. However, the underlying molecular mechanism by which puerarin interacts with receptor activator of nuclear factor kappa-B ligand (RANKL)-mediated osteoclast formation in vitro and wear particle-stimulated osteolysis in vivo has not been reported. In this work, the protective effects exerted by puerarin on titanium particle-stimulated bone destruction in vivo and on RANKL-induced osteoclast activation in osteoclastic precursor cells in vitro were investigated. As expected, puerarin significantly inhibited wear particle-mediated bone resorption and proinflammatory cytokine productions in a calvarial resorption model. Additionally, puerarin inhibited RANKL-induced osteoclast activation, bone resorption ability, and F-actin ring formation in vitro as puerarin concentration increased. Furthermore, mechanistic investigation indicated that reduced RANKL-stimulated MEK/ERK/NFATc1 signaling cascades might regulate the protective effect of puerarin. Conclusively, these results indicate that puerarin, a type of polyphenol, might serve as a protective agent to prevent osteoclast-related osteolytic diseases.

SUBMITTER: Yang C 

PROVIDER: S-EPMC6779862 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Puerarin Exerts Protective Effects on Wear Particle-Induced Inflammatory Osteolysis.

Yang Chao C   Li Juehong J   Zhu Kechao K   Yuan Xiangwei X   Cheng Tao T   Qian Yebin Y   Zhang Xianlong X  

Frontiers in pharmacology 20191001


Wear particle-stimulated inflammatory bone destruction and the consequent aseptic loosening remain major postoperative problems for artificial joints. Studies have indicated that puerarin promotes osteogenesis and alleviates lipopolysaccharide-induced osteoclastogenesis <i>in vitro</i>. However, the underlying molecular mechanism by which puerarin interacts with receptor activator of nuclear factor kappa-B ligand (RANKL)-mediated osteoclast formation <i>in vitro</i> and wear particle-stimulated  ...[more]

Similar Datasets

| S-EPMC6371946 | biostudies-literature
| S-EPMC3386559 | biostudies-literature
| S-EPMC5349296 | biostudies-literature
2023-06-17 | GSE234863 | GEO
| S-EPMC4476949 | biostudies-literature
| S-EPMC6169369 | biostudies-literature
| S-EPMC4750042 | biostudies-other
| S-EPMC3324493 | biostudies-literature
| S-EPMC8429634 | biostudies-literature
2008-01-01 | GSE7103 | GEO